Related Experiment Video
Updated: Aug 15, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.4K
Association Between Nonadherence and Transient Hyperuricemia in Pediatric Kidney Transplantation
Y Morizawa1, H Satoh2, M Arai2
1Department of Urology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
Transplantation Proceedings
|December 29, 2022
Summary
Nonadherence in pediatric kidney transplant (KTx) patients is hard to detect. Transient hyperuricemia is a key risk factor, suggesting monitoring it can help identify nonadherence early.
Area of Science:
- Pediatric Nephrology
- Transplant Medicine
- Clinical Research
Background:
- Nonadherence is a major challenge in pediatric kidney transplantation, negatively impacting graft survival and outcomes.
- Detecting nonadherence during routine follow-ups is difficult.
- This study explored risk factors for nonadherence in pediatric kidney transplant recipients.
Purpose of the Study:
- To investigate risk factors for nonadherence in pediatric kidney transplant (KTx) recipients.
- To specifically examine the role of unexplained transient hyperuricemia as a risk factor.
- To identify potential early indicators of nonadherence.
Main Methods:
- Retrospective study of 167 pediatric patients who underwent kidney transplantation.
- Cox proportional hazards analysis was used to assess risk factors.
- Evaluated factors included age, sex, BMI SD score, transient hyperuricemia, hypertension, and follow-up duration.
Main Results:
- Nonadherence was observed in 11% of patients (19 out of 167).
- Transient hyperuricemia was diagnosed in 20% of patients (34 out of 167), a median of 14 months post-KTx.
- Multivariate analysis identified transient hyperuricemia as the sole independent risk factor for nonadherence.
Conclusions:
- Transient hyperuricemia is a significant risk factor for nonadherence in pediatric kidney transplant recipients.
- Monitoring for transient hyperuricemia may enable earlier detection of nonadherence.
- This finding can inform strategies for improving long-term graft survival.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
49
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
49
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
53
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
01:16Kidney Transplant III: Nursing Management
56
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
56
01:28Kidney Transplant I: Introduction
32
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
32
01:29Acute Kidney Injury III: Clinical Manifestations
56
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
56
01:22Acute Kidney Injury I: Introduction
53
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
53